Expression of insulin-like growth factor binding proteins and collagen in experimental colitis in rats

European Journal of Gastroenterology and Hepatology

Volumn 13, Issue 7, 2001, Pages 851-858

  Zeeh, Jörg M ^a   Riley, Nora E ^a   Hoffmann, Peter ^a   Reinshagen, Max ^b   Goebell, Harald ^a   Gerken, Guido ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

2,4,6 trinitrobenzenesulphonic acid (TNBS) induced colitis; Insulin like growth factor binding proteins; Insulin like growth factor 1; Rat colonic smooth muscle cells; Stricture formation

Indexed keywords

COLLAGEN; COLLAGENASE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C;

ANIMAL MODEL; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CROHN DISEASE; DOWN REGULATION; ENZYME ACTIVITY; INTESTINE MUSCLE; MALE; MUSCLE GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; ULCERATIVE COLITIS; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELLS, CULTURED; COLITIS; COLLAGEN; COLON; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MALE; MUSCLE, SMOOTH; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RNA, MESSENGER; TRINITROBENZENESULFONIC ACID;

EID: 0034948082     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/00042737-200107000-00014     Document Type: Article

References (42)

1. Graham MF, Diegelmann RF, Elson CO, Lindblad RF, Gotschalk N, Gay S, Gay R. Collagen content and types in the intestinal strictures of Crohn’s disease. Gastroenterology 1988; 94: 257-265.
2. Uh ST, Inoue Y, King TE Jr, Chan ED, Newman LS, Riches DW. Morphometric analysis of insulin-like growth factor-1 localization in lung tissues of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 158: 1626-1635.
3. Allen JT, Knight RA, Bloor CA, Spiteri MA. Enhanced insulin-like growth factor binding protein-related protein 2 (connective tissue growth factor) expression in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Cell Mol Biol 1999; 21: 693-700.
4. Delaughter MC, Taffet GE, Fiorotto ML, Entman ML, Schwartz RJ. Local insulin-like growth factor 1 expression induces physiologic, then pathologic cardiac hypertrophy in transgenic mice. FASEB J 1999; 13: 1923-1929.
5. Svegliati-Baroni G, Ridolfi F, DiSario A, Casini A, Marucci L, Gaggiotti G. et al. Insulin and insulin-like growth factor-1 stimulate proliferation and type 1 collagen accumulation by human hepatic stellate cells: Differential effects on signal transduction pathways. Hepatology 1999; 29: 1743-1751.
6. Nissley P, Lopaczynski W. Insulin-like growth factor receptors. Growth Factors 1991; 5: 29-43.
7. Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983; 132: 6-13.
8. Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Addendum. Anal Biochem 1984; 137: 266-270.
9. Elgin RG, Busby WH Jr, Clemmons DR. An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-1. Proc Natl Acad Sci USA 1987; 84: 3254-3258.
10. Jones JI, Gockerman A, Busby WH Jr, Camacho-Hubner C, Clemmons DR. Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-1. J Cell Biol 1993; 121: 679-687.
11. Andress DL, Birnbaum RS. Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J Biol Chem 1992; 267: 22467-22472.
12. Conover CA, Kiefer MC. Regulation and biological effect of endogenous insulin-like growth factor binding protein-5 in human osteoblastic cells. J Clin Endocrinol Metab 1993; 76: 1153-1159.
13. Zimmermann EM, Li L, Hou YT, Cannon M, Christman GM, Bitar KN. IGF-1 induces collagen and IGFBP-5 mRNA in rat intestinal smooth muscle. Am J Physiol 1997; 273: 875-882.
14. Upton FZ, Francis GL, Ross M, Wallace JC, Ballard FJ. Production and characterization of recombinant chicken insulin-like growth factor-1 from Escherichia coli. J Mol Endocrinol 1992; 9: 83-92.
15. Read LC, Tomas FM, Howarth GS, Martin AA, Edson KJ, Gillespie CM. et al. Insulin-like growth factor-1 and its N-terminal modified analogues induce marked gut growth in dexamethasone-treated rats. J Endocrinol 1992; 133: 421-431.
16. Vanderhoof JA, McCusker RH, Clark R, Mohammadpour H, Blackwood DJ, Harty RF, Park JH. Truncated and native insulin-like growth factor 1 enhance mucosal adaptation after jejunoileal resection. Gastroenterology 1992; 102: 1949-1956.
17. Zeeh JM, Procaccino F, Hoffmann P, Zittel TT, Eysselein VE, McRoberts JA. Colonic smooth muscle in rats is a major target of insulin-like growth factor in vivo and in vitro. Gastroenterology 1995; 108: A1019.
18. Hansson HA, Petruson B, Petruson K. Immunohistochemical demonstration of insulin-like growth factor 1 in inflammatory lesions in Wegener’s granulomatosis and idiopathic midline destructive disease. Scand J Rheumatol 1989; 18: 133-141.
19. Jennische E, Skottner A, Hansson H. Dynamic changes in insulin-like growth factor 1 immunoreactivity correlate to repair events in rat ear after freeze-thaw injury. Exper Molec Path 1987; 47: 193-201.
20. Cohen JA, Zimmermann EM, Sartor RB. et al. IGF-I and IGF-II are overexpressed in inflamed and strictured intestine in Crohn’s disease [Abstract]. Gastroenterology 1993; 104: A683.
21. Zimmermann EM, Sartor RB, McCall RD, Pardo M, Bender D, Lund PK. Insulin-like growth factor 1 and interleukin 1b messenger RNA in a rat model of granulomatous enterocolitis and hepatitis. Gastroenterology 1993; 105: 399-409.
22. Zeeh JM, Hoffmann P, Sottili M, Eysselein VE, McRoberts JA. Upregulation of insulin-like growth factor 1 binding sites in experimental colitis in rats. Gastroenterology 1995; 108: 644-652.
23. Zeeh JM, Mohapatra N, Lund PK, Eysselein VE, McRoberts JA. Differential expression and localization of IGF-1 and IGF-binding proteins in inflamed rat colon. J Recept Signal Transduct Res 1998; 18: 265-280.
24. Zeeh JM, Ennes HS, Hoffmann P, Procaccino F, Eysselein VE, Snape WJ Jr, McRoberts JA. Expression of insulin-like growth factor-1 receptors and binding proteins by colonic smooth muscle cells. Am J Physiol 1996; 272: 481-487.
25. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
26. Hossenlopp P, Seurin D, Segovia-Quinson B, Harddouin S, Binoux M. Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anals Biochem 1986; 154: 138-143.
27. Rosenfeld RG, Pham H, Oh Y, Ocrant I. Characterization of insulin-like growth factor binding proteins in cultured rat pituitary cells. Endrocrinology 1989; 124: 2867-2874.
28. Menke A, Yamaguchi H, Gress TM, Adler G. Extracellular matrix is reduced by inhibition of transforming growth factor beta-1 in pancreatitis in the rat. Gastroenterology 1997; 113: 295-303.
29. Olanrewaju H, Patel L, Seidel ER. Trophic action of local intraileal infusion of insulin-like growth factor 1: polyamine dependence. Am J Physiol 1992; 263: 282-286.
30. McCarthy TL, Centrella M, Canalis E. Insulin-like growth factor (IGF) and bone. Connect Tissue Res 1989; 20: 277-282.
31. Silbermann M. In-vitro systems for inducers of cartilage and bone development. Biomaterials 1990; 11: 47-49.
32. Schmid C, Guler HP, Rowe D, Froesch ER. Insulin-like growth factor 1 regulates type I procollagen messenger ribonucleic acid steady state levels in bone of rats. Endocrinology 1989; 125: 1575-1580.
33. Canalis E, Gabbitas B. Skeletal growth factors regulate the synthesis of insulin-like growth factor binding protein-5 in bone cell cultures. J Biol Chem 1995; 270: 10771-10776.
34. Lee TC, Gold LI, Reibman J, Aston C, Begin R, Rom WN, Jagirdar J. Immunohistochemical localization of transforming growth factor-beta and insulin-like growth factor-1 in asbestosis in the sheep model. Int Arch Occup Environ Health 1997; 69: 157-164.
35. Hayashi T, Stetler-Stevenson WG, Fleming MV, Fishback N, Koss MN, Liotta LA. et al. Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. Am J Pathol 1996; 149: 1241-1256.
36. Baxter RC, Martin JL. Binding proteins for the insulin-like growth factors: structure, regulation and function. Prog Growth Factor Res 1989; 1: 49-68.
37. Baxter RC. The insulin-like growth factors and their binding proteins. Comp Biochem Physiol [B] 1988; 91: 229-235.
38. Mourelle M, Guarner F, Malagelada JR. Polyunsaturated phosphatidylcholine prevents stricture formation in a rat model of colitis. Gastroenterology 1996; 110: 1093-1097.
39. Graham MF, Bryson GR, Diegelmann F. Transforming growth factor B-1 selectively augments collagen synthesis by human intestinal smooth muscle cells. Gastroenterology 1993; 99: 447-453.
40. Graham MF, Willey A, Adams J, Yager D, Diegelmann RF. Interleukin-1-beta downregulates collagen and augments collagenase expression in human intestinal smooth muscle cells. Gastroenterology 1996; 110: 344-350.
41. Bushman TL, Kuemmerle JF. IGFBP-3 and IGFBP-5 production by human intestinal muscle: Reciprocal regulation by endogenous TGF-beta-1. Am J Physiol 1998; 275: 1282-1290.
42. Zimmermann EM, Sartor RB, Pardo M. et al. The extracellular matrix-associated IGF-1 binding protein-5 mRNA is upregulated in a rat model of chronic intestinal inflammation and fibrosis [Abstract]. Gastroenterology 1994; 106: A796.